Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation

Type of Cancer
Unknown

Site
Bethesda

Protocol Number
FT-2102

To Learn More Call
(201)-510-0950